ABLYNX PROMOTED TO THE BELGIAN MID-CAP INDEX>
ABLYNX PROMOTED TO THE BELGIAN MID-CAP INDEX
(Thomson Reuters ONE) - GHENT, Belgium, 2 July 2009 - Ablynx [Euronext Brussels: ABLX], apioneer in the discovery and development of Nanobodies®, a novelclass of antibody-derived therapeutic proteins, announced today itspromotion to the Belgian Mid-Cap Index (Bel Mid Index or BELMID) from1 July 2009.The entry of Ablynx to the Bel Mid Index is dependent upon Ablynx'smarket capitalization, free float and velocity.Dr. Edwin Moses, Chief Executive Officer and Chairman of Ablynxcommented: "The promotion of Ablynx to the Bel Mid Index is atestament to the considerable progress Ablynx has made since our IPO.We have a strong cash position and the financial turmoil over thelast year has not directly negatively affected Ablynx. We continue tobuild and diversify our shareholder base, both domestically andinternationally. There are now three Nanobodies® in clinicaldevelopment and our lead programme, ALX-0081, a novelanti-thrombotic, is on track to initiate Phase II during Q3. Earlierthis week, we announced that ALX-0061, our novel Nanobody® -basedtherapeutic programme against IL6R, has entered preclinicaldevelopment for the treatment of autoimmune and inflammatorydiseases." Dr Moses added: "Our diverse product portfolio illustratesthe breadth of work across several therapeutic areas which is beingundertaken to exploit the significant potential of our Nanobody®platform." -ends-For more information, please contact:For international media enquiries: College Hill Life SciencesSue Charles, Justine Lamond,Dr. John McIntyret: +44 (0)20 7866 7857e: ablynx(at)collegehill.comAblynx:Dr. Edwin MosesChairman and CEOt: +32 (0)9 262 00 07m: +44 (0)7771 954 193 / +32 (0)473 39 50 68e: edwin.moses(at)ablynx.comEva-Lotta AllanChief Business Officert: +32 (0)9 262 00 75m: +32 (0)475 78 36 21 / +44 (0)7990 570 900e: eva-lotta.allan(at)ablynx.comhttp://hugin.info/137912/R/1326978/312528.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
" alt="Brunel Nederland acquires shares of For All Finance>
">
Datum: 02.07.2009 - 16:35 Uhr
Sprache: Deutsch
News-ID 1002205
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
London
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 242 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ABLYNX PROMOTED TO THE BELGIAN MID-CAP INDEX>
"
steht unter der journalistisch-redaktionellen Verantwortung von
Ablynx (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
